Donates also said the nonprofit never had any employees, and that Granados stopped being officially involved with the charity ...

Just published is the third new study showing that TM is highly effective in reducing stress in a wide array of populations. This meta-analysis ...

In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story ...

The scientific team at JuveXO®, one of the most advanced exosome-based solutions available today, is thrilled to announce the ...

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce ...

AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex ...

Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targ ...

Two materials physicists at The University of Sydney have found a possible explanation for the huge amount of molecular ...

Asymmetric interactions between molecules may serve as a stabilizing factor for biological systems. A new model by ...

Researchers led by Keigo Morita and Shinya Kuroda of the University of Tokyo have revealed a temporal disruption in the ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...